Jin Medical International Ltd. (ZJYL)

NASDAQ: ZJYL · Real-Time Price · USD

0.6407

+0.0389 (6.46%)

At close: Jul 15, 2025, 4:00 PM

0.6103

-0.0304 (-4.74%)

After-hours: Jul 15, 2025, 5:34 PM EDT

Jin Medical International Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2018 - 2019
Revenue	23.5	19.82	19.19	20.76	16.19	Upgrade
Revenue Growth (YoY)	18.57%	3.29%	-7.58%	28.22%	-20.49%	Upgrade
Cost of Revenue	13.89	12.86	12.83	14.18	10.7	Upgrade
Gross Profit	9.61	6.96	6.36	6.59	5.5	Upgrade
Selling, General & Admin	4.37	2.37	2.18	2.16	1.88	Upgrade
Research & Development	1.5	1.54	1.89	1.57	1.26	Upgrade
Other Operating Expenses	0.11	0.18	0.16	0.23	-	Upgrade
Operating Expenses	5.97	4.1	4.23	3.95	3.14	Upgrade
Operating Income	3.64	2.87	2.13	2.63	2.35	Upgrade
Interest Expense	-	-	-	-0.01	-0.11	Upgrade
Interest & Investment Income	0.47	0.18	0.18	-	-	Upgrade
Currency Exchange Gain (Loss)	-0.03	-0.05	0.19	0.06	-0.01	Upgrade
Other Non Operating Income (Expenses)	0.11	0.22	0.24	0.19	0.12	Upgrade
Pretax Income	4.18	3.22	2.74	2.88	2.35	Upgrade
Income Tax Expense	0.76	0.34	0.04	0.25	0.15	Upgrade
Earnings From Continuing Operations	3.42	2.88	2.71	2.63	2.21	Upgrade
Minority Interest in Earnings	0.26	-	-	-	-	Upgrade
Net Income	3.68	2.88	2.71	2.63	2.21	Upgrade
Net Income to Common	3.68	2.88	2.71	2.63	2.21	Upgrade
Net Income Growth	27.71%	6.34%	2.84%	19.30%	-39.52%	Upgrade
Shares Outstanding (Basic)	156	145	135	135	400	Upgrade
Shares Outstanding (Diluted)	156	145	135	135	400	Upgrade
Shares Change (YoY)	7.81%	7.51%	-	-66.25%	-	Upgrade
EPS (Basic)	0.02	0.02	0.02	0.02	0.01	Upgrade
EPS (Diluted)	0.02	0.02	0.02	0.02	0.01	Upgrade
EPS Growth	18.46%	-1.08%	2.84%	253.54%	-39.53%	Upgrade
Free Cash Flow	-1.35	2.99	1.54	5.8	2.36	Upgrade
Free Cash Flow Per Share	-0.01	0.02	0.01	0.04	0.01	Upgrade
Gross Margin	40.89%	35.14%	33.13%	31.72%	33.95%	Upgrade
Operating Margin	15.48%	14.46%	11.10%	12.67%	14.54%	Upgrade
Profit Margin	15.64%	14.52%	14.10%	12.67%	13.62%	Upgrade
Free Cash Flow Margin	-5.75%	15.10%	8.03%	27.93%	14.58%	Upgrade
EBITDA	3.88	3.09	2.49	2.98	2.68	Upgrade
EBITDA Margin	16.50%	15.60%	12.99%	14.34%	16.58%	Upgrade
D&A For EBITDA	0.24	0.23	0.36	0.35	0.33	Upgrade
EBIT	3.64	2.87	2.13	2.63	2.35	Upgrade
EBIT Margin	15.48%	14.46%	11.10%	12.67%	14.54%	Upgrade
Effective Tax Rate	18.26%	10.67%	1.32%	8.63%	6.25%	Upgrade
Revenue as Reported	23.5	19.82	19.19	20.76	16.19	Upgrade

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q